MedTech

YTD

ALL

Why Robinhood?

You can watch MedTech and buy or sell other stocks, ETFs, and their options commission-free!

About MTAC

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

CEO

Mary T. Szela, MBA

CEOMary T. Szela, MBA

Employees

110

Employees110

Headquarters

Westminster, Colorado

HeadquartersWestminster, Colorado

Founded

Employees

110

Employees110

MTAC Key Statistics

Market cap

157.81M

Market cap157.81M

Price-Earnings ratio

-4.37

Price-Earnings ratio-4.37

Dividend yield

—

Dividend yield—

Average volume

54.97K

Average volume54.97K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.04

52 Week high$6.04

52 Week low

$3.50

52 Week low$3.50

People also own

Based on the portfolios of people who own MTAC. This list is generated using Robinhood data, and it’s not a recommendation.